Evaluating preclinical efficacy - PubMed (original) (raw)
Evaluating preclinical efficacy
Mark A Atkinson. Sci Transl Med. 2011.
Abstract
Recent disappointing results of clinical trials seeking type 1 diabetes (T1D) reversal suggest the need for a reevaluation of our translational efforts. This Commentary explores the need for standards in evaluating therapeutic efficacy in preclinical models of T1D.
Similar articles
- What will it take to get therapies approved for type 1 diabetes?
Fleming A. Fleming A. Ann N Y Acad Sci. 2008 Dec;1150:25-31. doi: 10.1196/annals.1447.043. Ann N Y Acad Sci. 2008. PMID: 19120263 - Mucosal insulin vaccination for type 1 diabetes prevention.
Bonifacio E, Achenbach P, Pan L, Ziegler AG. Bonifacio E, et al. Exp Clin Endocrinol Diabetes. 2008 Sep;116 Suppl 1:S26-9. doi: 10.1055/s-2008-1081484. Epub 2008 Sep 5. Exp Clin Endocrinol Diabetes. 2008. PMID: 18777449 Review. - Type 1 diabetes: etiology, immunology, and therapeutic strategies.
van Belle TL, Coppieters KT, von Herrath MG. van Belle TL, et al. Physiol Rev. 2011 Jan;91(1):79-118. doi: 10.1152/physrev.00003.2010. Physiol Rev. 2011. PMID: 21248163 Review. - Predictive value of the efficacy of glaucoma medications in animal models: preclinical to regulatory studies.
Stewart WC, Magrath GN, Demos CM, Nelson LA, Stewart JA. Stewart WC, et al. Br J Ophthalmol. 2011 Oct;95(10):1355-60. doi: 10.1136/bjo.2010.188508. Epub 2010 Dec 17. Br J Ophthalmol. 2011. PMID: 21169272 Review. - Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency.
Xue S, Wasserfall CH, Parker M, Brusko TM, McGrail S, McGrail K, Moore M, Campbell-Thompson M, Schatz DA, Atkinson MA, Haller MJ. Xue S, et al. Ann N Y Acad Sci. 2008 Dec;1150:152-6. doi: 10.1196/annals.1447.049. Ann N Y Acad Sci. 2008. PMID: 19120286
Cited by
- Reversal of diabetes by an oral Salmonella-based vaccine in acute and progressive diabetes in NOD mice.
Cobb J, Rawson J, Gonzalez N, Orr C, Kandeel F, Husseiny MI. Cobb J, et al. PLoS One. 2024 May 23;19(5):e0303863. doi: 10.1371/journal.pone.0303863. eCollection 2024. PLoS One. 2024. PMID: 38781241 Free PMC article. - Cell-Surface ZnT8 Antibody Prevents and Reverses Autoimmune Diabetes in Mice.
Kasinathan D, Guo Z, Sarver DC, Wong GW, Yun S, Michels AW, Yu L, Sona C, Poy MN, Golson ML, Fu D. Kasinathan D, et al. Diabetes. 2024 May 1;73(5):806-818. doi: 10.2337/db23-0568. Diabetes. 2024. PMID: 38387059 - HAMSAB diet ameliorates dysfunctional signaling in pancreatic islets in autoimmune diabetes.
Vandenbempt V, Eski SE, Brahma MK, Li A, Negueruela J, Bruggeman Y, Demine S, Xiao P, Cardozo AK, Baeyens N, Martelotto LG, Singh SP, Mariño E, Gysemans C, Gurzov EN. Vandenbempt V, et al. iScience. 2023 Dec 10;27(1):108694. doi: 10.1016/j.isci.2023.108694. eCollection 2024 Jan 19. iScience. 2023. PMID: 38213620 Free PMC article. - The N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan Improves Glucose Homeostasis and Preserves Pancreatic Islets in NOD Mice.
Wörmeyer L, Nortmann O, Hamacher A, Uhlemeyer C, Belgardt B, Eberhard D, Mayatepek E, Meissner T, Lammert E, Welters A. Wörmeyer L, et al. Horm Metab Res. 2024 Mar;56(3):223-234. doi: 10.1055/a-2236-8625. Epub 2024 Jan 2. Horm Metab Res. 2024. PMID: 38168730 Free PMC article. - RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes.
Kondegowda NG, Filipowska J, Do JS, Leon-Rivera N, Li R, Hampton R, Ogyaadu S, Levister C, Penninger JM, Reijonen H, Levy CJ, Vasavada RC. Kondegowda NG, et al. Sci Adv. 2023 Nov 3;9(44):eadf5238. doi: 10.1126/sciadv.adf5238. Epub 2023 Nov 1. Sci Adv. 2023. PMID: 37910614 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical